Cardinal Health
Cardinal Health
CAH
NYSE
112.72
USD
-7.07%
Dividends
Payment date
15 Jan 2025
Ex-date
2 Jan 2025
Amount
0.51 USD
About
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products.
The Company’s segments include Pharmaceutical and Specialty Solutions (PSS) and Global Medical Products and Distribution (GMPD). The PSS segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets.
It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It also offers Olathe medical devices..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 1.5M |
| Three Month Average Volume | 40.7M |
| High Low | |
| Fifty-Two Week High | 116.04 USD |
| Fifty-Two Week Low | 85.82 USD |
| Fifty-Two Week High Date | 13 Mar 2024 |
| Fifty-Two Week Low Date | 02 Oct 2023 |
| Price and Volume | |
| Current Price | 112.72 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 5.02% |
| Thirteen Week Relative Price Change | 6.09% |
| Twenty-Six Week Relative Price Change | -9.57% |
| Fifty-Two Week Relative Price Change | 3.01% |
| Year-to-Date Relative Price Change | -5.57% |
| Price Change | |
| One Day Price Change | 0.46% |
| Thirteen Week Price Change | 13.55% |
| Twenty-Six Week Price Change | -0.57% |
| Five Day Price Change | 3.00% |
| Fifty-Two Week Price Change | 29.07% |
| Year-to-Date Price Change | 11.83% |
| Month-to-Date Price Change | 11.79% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | -13.16803 USD |
| Book Value Per Share (Most Recent Quarter) | -13.16803 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | -39.60246 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | -39.60246 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 11.57895 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 918.3279 USD |
| Revenue Per Share (Trailing Twelve Months) | 918.3279 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 2.0024 USD |
| Dividend Per Share (Trailing Twelve Months) | 2.0024 USD |
| Dividend Per Share (5 Year) | 1.96328 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 3.44939 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 3.46349 USD |
| Normalized (Last Fiscal Year) | 6.74899 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 3.47755 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 3.4859 USD |
| Including Extraordinary Items (Last Fiscal Year) | 3.44939 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 3.46349 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 21.03689 USD |
| Cash Per Share (Most Recent Quarter) | 21.03689 USD |
| Cash Flow Per Share (Last Fiscal Year) | 6.4251 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 6.32794 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 11.1417 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 1 |
| Cash Flow Revenue (Trailing Twelve Months) | 1 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 0.53% |
| Pretax Margin (Last Fiscal Year) | 0.53% |
| Pretax Margin (5 Year) | -0.26% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 3.27% |
| Gross Margin (Trailing Twelve Months) | 3.27% |
| Gross Margin (5 Year) | 3.71% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 0.55% |
| Operating Margin (Trailing Twelve Months) | 0.55% |
| Operating Margin (5 Year) | -0.25% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 0.38% |
| Net Profit Margin (Trailing Twelve Months) | 0.38% |
| Net Profit Margin (5 Year) | -0.31% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 8.66% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 11.77% |
| Revenue Growth (3 Year) | 9.28% |
| Revenue Change (Trailing Twelve Months) | 10.66% |
| Revenue Per Share Growth | 13.69% |
| Revenue Growth (5 Year) | 11.77% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 9.27% |
| Total Debt (5 Year) | -8.71% |
| Dividends | |
| Dividend Growth (3 Year) | 1.00% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 4,792.32% |
| EPS Change (Trailing Twelve Months) | 174.53% |
| EPS Growth (3 Year) | -5.30% |
| EPS Growth (5 Year) | 18.40% |
| EBITDA | |
| EBITDA (5 Year) | 0.44% |
| EBITDA (5 Year Interim) | 0.26% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -16.71% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 10 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 10 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -41,000,000 |
| Net Debt (Last Fiscal Year) | -41,000,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 33 |
| PE Normalized (Last Fiscal Year) | 17 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 28 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 99 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 11 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 33 |
| Dividends | |
| Dividend Yield (5 Year) | 2.77% |
| Dividend Yield | 1.79% |
| Current Dividend Yield | 1.78% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | -100,000 |
| Price to Book (Most Recent Quarter) | -100,000 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | -100,000 |
| Long Term Debt to Equity (Most Recent Quarter) | -100,000 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 58.22% |
| Payout Ratio (Trailing Twelve Months) | 58.10% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 48 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 50 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 2.8B |
| Free Cash Flow (Trailing Twelve Months) | 2.8B |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 42 |
| Net Interest Coverage (Trailing Twelve Months) | 39 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | -100,000 |
| Total Debt to Equity (Most Recent Quarter) | -100,000 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 1.93% |
| Return on Assets (Trailing Twelve Months) | 1.93% |
| Return on Assets (5 Year) | -1.32% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -99,999.99% |
| Return on Equity (Trailing Twelve Months) | -99,999.99% |
| Return on Equity (5 Year) | -193.20% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 8.94% |
| Return on Investment (Trailing Twelve Months) | 8.94% |
| Return on Investment (5 Year) | -4.04% |